by Jenn Porter | Feb 18, 2020 | Canadian Regulatory, Cosmetics, European Regulatory, Innovation, Medical Devices, Natural Health Products, Our View, Research/Science/Technology, U.S. Regulatory
The new year has just begun, and it is already friendlier than last year- at least more animal friendly that is! It is clear in today’s society that cruelty-free products are very important to cosmetic consumers and will likely continue to increase in importance....
by Jenn Porter | Feb 15, 2020 | Canadian Regulatory, Cosmetics, European Regulatory, Events/Company Updates, Innovation, Medical Devices, Natural Health Products, OTC Drugs, Our View, Research/Science/Technology, U.S. Regulatory, Uncategorized
A lot of people have been contacting me about complaints made about their innovations. Now to be clear, I’m not referring to things like Google reviews although these may or may not be relevant. I am thinking of complaints made directly to the company about the...
by Jenn Porter | Feb 15, 2020 | Canadian Regulatory, Cosmetics, European Regulatory, Innovation, Medical Devices, Natural Health Products, Our View, Research/Science/Technology
Just over one week into the new decade and the medical device industry is already launching into the future. The innovative researchers at Massachusetts Institute of Technology (MIT) have taken a large step into the future of ultrasound imaging technologies. They have...
by Jenn Porter | Jan 22, 2020 | Canadian Regulatory, Events/Company Updates, Innovation, Our View, Research/Science/Technology, Uncategorized
During the course of my career, I have seen fortunes made and fortunes lost. I have seen companies start in a basement and within five years sell for tens or hundreds of millions of dollars. I have also seen entrepreneurs having to sell their homes and cars and move...
by Jenn Porter | Jan 7, 2020 | Canadian Regulatory, Cosmetics, European Regulatory, Natural Health Products, OTC Drugs, Research/Science/Technology, U.S. Regulatory
Health Canada has updated its assessment requirements for Nitrosamines in pharmaceutical products. Nitrosamines are, defined by the World Health Organization, as “any molecule containing the nitroso functional group. These molecules are of concern because nitrosamine...
by Jenn Porter | Dec 23, 2019 | Canadian Regulatory, Cosmetics, Natural Health Products, Research/Science/Technology, Uncategorized
Earlier this month, Health Canada released a list of new amendments to both the Restricted and Prohibited Cosmetic Ingredient Hotlists. The list included changes to the classification or conditions of use on four ingredients, all already present on the Cosmetic...
Recent Comments